Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide

Detalles Bibliográficos
Autores principales: Ryder, Robert E.J., Laubner, Katharina, Benes, Marek, Haluzik, Martin, Munro, Lynne, Frydenberg, Harry, Teare, Julian P., Ruban, Aruchuna, Fishman, Sigal, Santo, Erwin, Stengel, Rainer, De Jonge, Charlotte, Greve, Jan W., Cohen, Ricardo V., Aboud, Cristina M., Holtmann, Gerald J., Rich, Graeme, McMaster, Jess J., Battelino, Tadej, Kotnik, Primoz, Byrne, James P., Mason, John C., Bessell, Justin, Bascomb, Jeanine, Kow, Lillian, Collins, Janes, Chisholm, Jacob, Pferschy, Peter N., Sourij, Harald, Cull, Melissa L., Wyres, Melanie C., Drummond, Russell, McGowan, Barbara, Amiel, Stephanie A., Yadagiri, Mahi, Sen Gupta, Piya, Aberle, Jens, Seufert, Jochen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2023
Materias:
e-Letters – Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090889/
https://www.ncbi.nlm.nih.gov/pubmed/36716004
http://dx.doi.org/10.2337/dc22-1952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090889/
https://www.ncbi.nlm.nih.gov/pubmed/36716004
http://dx.doi.org/10.2337/dc22-1952

Ejemplares similares